Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

TARA

Protara Therapeutics, Inc.

CIK 0001359931 · Nasdaq

NasdaqHealth CareBiological Products, (No Diagnostic Substances)
$3.85
↓ 0.05 (-1.28%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership; Risks: Fundamentals, Technicals; Excluded: Options (no data)

Key stats

Market Cap
$227.52M
P/E Ratio
-3.25
EPS
-1.34
Dividend Yield
Not covered
52W Position
18%
Beta
1.00

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
1.41
P/S
Not covered
EV/Revenue
Not covered
ROE
-43.4%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

250 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 18%
$3.00$7.82

Latest Financials

2025-12-31 FY
Revenue
–
Net Income
-$57.44M
Total Assets
$209.47M
Free Cash Flow
-$56.46M

Recent news